Endoscopy 2008; 40(2): 115-119
DOI: 10.1055/s-2007-966959
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Risk factors for severe delayed postpolypectomy bleeding

M.  S.  Sawhney1, 2, 3 , N.  Salfiti1, 3 , D.  B.  Nelson1, 3 , F.  A.  Lederle2, 3 , J.  H.  Bond1, 3
  • 1Section of Gastroenterology Minneapolis Veterans Administration Medical Center, Minneapolis, USA
  • 2Center for Epidemiological and Clinical Research, Minneapolis Veterans Administration Medical Center, Minneapolis, USA
  • 3Department of Medicine, University of Minnesota, Minneapolis, USA
Weitere Informationen

Publikationsverlauf

submitted 4 April 2007

accepted after revision 28 August 2007

Publikationsdatum:
06. Februar 2008 (online)

Background and study aims: Postpolypectomy bleeding is a rare but serious adverse event. The aim of this study was to identify factors associated with the risk of severe delayed postpolypectomy bleeding.

Patients and methods: This was a case-control study, comparing cases who developed hematochezia and required medical evaluation 6 hours to 14 days after colonoscopic polypectomy, and control patients who underwent polypectomy without delayed bleeding, and who were selected in approximately a 3 : 1 ratio. The following risk factors were specified a priori: resuming anticoagulation (within 1 week following polypectomy), aspirin use, hypertension, and polyp diameter.

Results: Of the 4592 patients who underwent colonoscopy with polypectomy, 41 patients (0.9 %) developed delayed postpolypectomy bleeding (cases), and 132 patients were selected as controls. The mean age was 64.3 years for cases and 65.4 years for controls. Cases presented on average 6 days after polypectomy (range 1 - 14 days), and 48 % required blood transfusion (average 4.2 units, range 0 - 17). Two patients required surgery. Anticoagulation was resumed following polypectomy in 34 % of cases compared with 9 % of controls (OR 5.2; 95 % CI 2.2 - 12.5; P < 0.001). For every 1 mm increase in polyp diameter, the risk of hemorrhage increased by 9 % (OR 1.09; 95 % CI 1.0 - 1.2; P = 0.008). Hypertension (OR 1.1) and aspirin use (OR 1.1) did not increase the risk of postpolypectomy bleeding. In exploratory analysis, diabetes (OR 2.5) and coronary artery disease (OR 3.0) were associated with postpolypectomy hemorrhage, but the association was no longer statistically significant once adjusted for the use of anticoagulation.

Conclusions: Resuming anticoagulation following polypectomy and polyp diameter were strongly associated with increased risk of severe delayed postpolypectomy bleeding.

References

  • 1 Winawer S J, Zauber A G, O’Brien M J. et al . Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps.  N Engl J Med. 1993;  328 901-906
  • 2 Winawer S J, Zauber A G, Ho M N. et al . Prevention of colorectal cancer by colonoscopic polypectomy.  N Engl J Med. 1993;  329 1977-1981
  • 3 Nelson D B, McQuaid K R, Bond J H. et al . Procedural success and complications of large-scale screening colonoscopy.  Gastrointest Endosc. 2002;  55 307-314
  • 4 Rex D K, Lewis B S, Waye J D. Colonoscopy and endoscopic therapy for delayed post-polypectomy hemorrhage.  Gastrointest Endosc. 1992;  38 127-129
  • 5 Rosen L, Bub D S, Reed J F, Nastasee S A. Hemorrhage following colonoscopic polypectomy.  Dis Colon Rectum. 1993;  36 1126-1131
  • 6 Gibbs D H, Opelka F G, Beck D E. et al . Postpolypectomy colonic hemorrhage.  Dis Colon Rectum. 1996;  39 806-810
  • 7 Sorbi D, Norton I, Conio M. et al . Postpolypectomy lower GI bleeding: descriptive analysis.  Gastrointest Endosc. 2000;  51 690-696
  • 8 Hui A, Wong R MY, Ching J YL. et al . Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.  Gastrointest Endosc. 2004;  59 44-48
  • 9 Yousfi M, Gostout C, Baron T. et al . Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin.  Am J Gastroenterol. 2004;  99 1785-1789
  • 10 Heldwein W, Rosch T, Meining A. et al . The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies.  Endoscopy. 2005;  37 1116-1122
  • 11 Watabe H, Yamaji Y, Okamoto M. et al . Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyp-related factors and patient-related factors.  Gastrointest Endosc. 2006;  64 73-78
  • 12 Cepeda M, Boston R, Farrar J, Strom B. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders.  Am J Epidemiol. 2003;  158 280-287
  • 13 Eisen G M, Baron T H, Dominitz J A. et al . Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures.  Gastrointest Endosc. 2002;  55 775-779
  • 14 Garbay J R, Suc B, Rotman N. et al . Multicentre study of surgical complications of colonoscopy.  Br J Surg. 1996;  83 42-44
  • 15 Waye J D, Lewis B S, Yessayan S. Colonoscopy: a prospective report of complications.  J Clin Gastroenterol. 1992;  15 347-351
  • 16 Gage B, Waterman A, Shannon W. et al . Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.  JAMA. 2001;  285 2864-2870

M. S. Sawhney, MD

Section of Gastroenterology
Beth Israel Deaconess Medical Center
RABB-ROSE 101

330 Brookline Avenue
Boston, MA 02215
USA

Fax: +1-617-667-1171

eMail: msawhney@bidmc.harvard.edu